nan Mehta
University College London
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by nan Mehta.
Gene Therapy | 2012
Mehta; K Abi-Nader; Donald Peebles; E Benjamin; Wigley; B Torondel; Elisa Filippi; Sws Shaw; M Boyd; John Martin; Ian Zachary; Anna L. David
Increasing uterine artery blood flow (UABF) may benefit fetal growth restriction where impaired uteroplacental perfusion prevails. Based on previous short-term results, we examined the long-term effects of adenovirus vector-mediated overexpression of vascular endothelial growth factor-A165 (VEGF-A165) in the uterine artery (UtA). Transit-time flow probes were implanted around both UtAs of mid-gestation pregnant sheep (n=11) to measure UABF. A carotid artery catheter was inserted to measure maternal or fetal hemodynamics. Baseline UABF was measured over 3 days, before injection of adenovirus vector (5 × 1011 particles) encoding the VEGF-A165 gene (Ad.VEGF-A165) into one UtA and a reporter β-galactosidase gene (Ad.LacZ) contralaterally. UABF was then measured daily until term. At 4 weeks post injection, the increase in UABF was significantly higher in Ad.VEGF-A165 compared with Ad.LacZ-transduced UtAs (36.53% vs 20.08%, P=0.02). There was no significant effect on maternal and fetal blood pressure. Organ bath studies showed significantly lesser vasoconstriction (Emax 154.1 vs 184.7, P<0.001), whereas immunohistochemistry demonstrated a significantly increased number of adventitial blood vessels (140 vs 91, n=26, P<0.05) following Ad.VEGF-A165 transduction. Local overexpression of VEGF-A165 in the UtAs of pregnant mid-gestation sheep leads to a sustained long-term increase in UABF, which may be explained by neovascularization and altered vascular reactivity.
Archives of Disease in Childhood-fetal and Neonatal Edition | 2010
Mehta; K Abi-Nader; M Buitendyk; Sws Shaw; M Boyd; Ian Zachary; John Martin; Donald Peebles; Anna L. David
Introduction Impaired utero-placental perfusion leads to fetal growth restriction. The authors have shown a significant increase in blood flow in the uterine arteries (UAs) of pregnant sheep and a significantly reduced contractile response following local transduction with an adenovirus encoding VEGF-A165 (Ad.VEGF-A). The authors have now studied the effects of local over-expression of the VEGF-DΔNΔC isoform and investigated the mechanism behind the VEGF (−A and −DΔNΔC) induced effects. Method UAs of mid-gestation pregnant sheep were injected with adenovirus vectors (5×1011 particles) encoding the VEGF-DΔNΔC gene (Ad.VEGF-D) and a reporter β-galactosidase gene (Ad.LacZ) contra-laterally. Sheep were killed 4–7 days later. UAs were isolated and their vasoreactivity studied on an organ bath. Adventitial blood vessels were enumerated by anti-vWF immunohistochemistry. Endothelial cells (ECs) were isolated from the UAs of control mid-gestation pregnant sheep, cultured and infected with Ad.VEGF-A vector. Protein was extracted from these uterine artery endothelial cells (UAECs) infected ex vivo and assayed for endothelial nitric oxide synthase (eNOS) levels by Western blotting. Results There was a significant reduction in the UA contractile response following Ad.VEGF-D when compared to Ad.LacZ transduction (Emax 126.6±7.54 vs 159.9±10.96, p<0.001, n=5) and vasorelaxation was enhanced (pD2 (−log EC50) 9.05±0.14 vs 8.87±0.16, p=0.55, n=4). eNOS levels increased with rising adenovirus vector concentrations in UAECs transduced ex vivo. There were significantly higher numbers of blood vessels in the perivascular adventitia of Ad.VEGF-D transduced vessels compared to Ad.LacZ transduced vessels (140.6±15.1 vs 91.7±9.9, p<0.05). Conclusion Changes in eNOS levels and vascular remodeling may be the underlying mechanism of action of local VEGF over-expression in pregnant sheep UAs.
Presented at: Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, FINLAND. (2015) | 2015
Ca Rossi; Mehta; M Lees; John Martin; Ian Zachary; Donald Peebles; Anna L. David
In: (Proceedings) Annual Conference of the British-Society-for-Gene-and-Cell-Therapy. (pp. A15-A15). MARY ANN LIEBERT, INC (2015) | 2015
C Rossi; Mehta; M Lees; John Martin; Ian Zachary; Donald Peebles; Anna L. David
In: (Proceedings) Annual Conference of the British-Society-for-Gene-and-Cell-Therapy. (pp. A14-A14). MARY ANN LIEBERT, INC (2015) | 2015
A Swanson; C Rossi; K Ofir; Mehta; M Boyd; H Barker; A Ledwozyw; John Martin; Ian Zachary; Nj Sebire; Donald Peebles; Anna L. David
Presented at: 61st Annual Scientific Meeting of the Society-for-Gynecologic-Investigation (SGI), Florence, ITALY. (2014) | 2014
Am Swanson; K Ofir; Aa Glazewska; Sj Scott; Mehta; M Boyde; H Barker; John Martin; Ian Zachary; Donald Peebles; Anna L. David
In: Kilby, MD and Johnson, A and Oepkes, D, (eds.) Fetal Therapy. Cambridge University Press (2013) | 2013
Mehta; Anna L. David
Presented at: UNSPECIFIED. (2012) | 2012
Mehta; M Boyd; H Barker; A Avdic-Belltheus; Dj Carr; John Martin; Ian Zachary; Donald Peebles; Anna L. David
Presented at: UNSPECIFIED. (2012) | 2012
Dj Carr; Raymond P. Aitken; John S. Milne; Mehta; Donald Peebles; John Martin; Ian Zachary; Anna L. David; Jacqueline M. Wallace
Presented at: UNSPECIFIED. (2010) | 2010
Mehta; K Abi-Nader; M Buitendyk; M Boyd; Ian Zachary; John Martin; Donald Peebles; Anna L. David